Table 3:
Status at follow-up
| n | Median (IQR) or frequency (%) | |
|---|---|---|
| General condition | ||
| Age (years) | 36 | 53.5 (42.0–58.0) |
| Female | 36 | 9 (25.0) |
| Body mass index (BMI) (kg/m2) | 36 | 26.7 (23.2–30.0) |
| NYHA class | 36 | 2.0 (1.0–2.0) |
| Number of drugs currently taken | 36 | 8.0 (5.0–10.0) |
| Been to rehab | 36 | 35 (97.2) |
| Hospitalizations since ECLS | 36 | 2.0 (1.0–4.0) |
| Downstream adverse events | ||
| Myocardial infarction | 36 | 2 (5.6) |
| Stroke | 36 | 1 (2.8) |
| Downstream procedures | ||
| PCI | 36 | 5 (13.9) |
| Mitraclip | 36 | 0 |
| VAD implantation | 36 | 0 |
| Heart transplantation | 36 | 3 (8.3) |
| In need of care | 36 | 4 (11.1) |
| Degree of dependence (mRS) | 36 | 1.0 (1.0–2.0) |
| Health-related quality of life | ||
| SF-36 | ||
| Physical functioning | 36 | 72.5 (50.0–88.8) |
| Role physical | 36 | 62.5 (0.0–100.0) |
| Bodily pain | 36 | 80.0 (51.3–100.0) |
| General health | 36 | 52.0 (35.0–67.0) |
| Vitality | 36 | 50.0 (35.0–68.8) |
| Social functioning | 36 | 87.5 (62.5–100.0) |
| Role emotional | 36 | 100.0 (33.3–100.0) |
| Mental health | 36 | 76.0 (56.0–84.0) |
| Physical component summary | 36 | 45.2 (33.3–52.0) |
| Mental component summary | 36 | 52.9 (41.8–55.2) |
| Neurocognitive and psychological status | ||
| BDI-II score | 36 | 8.5 (2.3–18.8) |
| MoCA score | 29 | 26.0 (22.5–28.0) |
| NIHSS score | 27 | 1.0 (1.0–2.0) |
| Cardiopulmonary function | ||
| EKG | ||
| Sinus rhythm | 26 | 25 (96.2) |
| Atrial fibrillation | 26 | 1 (3.8) |
| LBBB | 26 | 3 (11.5) |
| Echocardiography | ||
| Left ventricular enddiastolic diameter (LVEDD) (mm) | 26 | 53.0 (46.8–63.0) |
| Ejection fraction (EF) (%) | 26 | 49.0 (37.3–55.3) |
| TAPSE (mm) | 26 | 20.0 (18.0–23.0) |
| Percentage of predicted 6MWD (%) | 21 | 68.8 (61.7–91.6) |
| End-organ function | ||
| Creatinine (mg/dl) | 31 | 1.1 (1.0–1.4) |
| Urea (mg/dl) | 31 | 43.0 (33.0–60.0) |
| Cystatin C (mg/l) | 31 | 1.2 (0.9–1.4) |
| GFR (ml/min) | 31 | 91.0 (69.0–99.0) |
| Bilirubin (mg/dl) | 31 | 0.8 (0.5–1.0) |
| GOT(U/l) | 31 | 28.0 (25.0–34.0) |
| GPT (U/l) | 31 | 26.0 (19.0–40.0) |
BDI-II: Beck Depression Inventory-II; IQR: interquartile range; LBBB: left bundle branch block; 6MWD: 6-minute walk distance; MoCA: Montreal Cognitive Assessment test; mRS: modified Rankin Scale; NIHSS: National Institutes of Health Stroke Scale; PCI: percutaneous coronary intervention; SF-36: 36-Item Short Form Survey; VAD: ventricular assist device.